Marizyme

(OTC) MRZM

Current Price$0.00

Market Cap$100

Since IPO (2010)-100%

5 Year-100%

1 Year-100%

1 Month+0%

Marizyme Financials at a Glance

Market Cap

$100

Revenue (TTM)

$183.42K

Net Income (TTM)

$22.02M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-5.79 (Low)

Dividend

$0.00

Beta (Volatility)

-5.79 (Low)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

-5.79 (Low)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

MRZM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Marizyme

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David L. Barthel, MBA

Website

www.marizyme.com

Headquarters

Jupiter, FL 33458, US

MRZM Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

-53%

Net Income Margin

-108%

Return on Equity

Return on Capital

54%

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

131.79M

Volume

Avg. Volume

Financials (TTM)

Gross Profit

$238.91K

Operating Income

$34.09M

EBITDA

$55.44M

Operating Cash Flow

$4.68M

Capital Expenditure

$0.00

Free Cash Flow

$4.68M

Cash & ST Invst.

$148.47K

Total Debt

$20.76M

Marizyme Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2024YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$210.78K

-261.5%

Gross Margin

0.00%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$7.69

N/A

Employees

N/A

Net Income

$1.96M

+94.0%

EBITDA

$644.00K

+97.4%

Quarterly Fundamentals

Name

Q3 2024YOY CHG

Net Cash

$26.59M

-25.9%

Accounts Receivable

$37.88K

-52.0%

Inventory

$26.87K

-72.9%

Long Term Debt

$355.18K

-55.9%

Short Term Debt

$26.30M

+26.5%

Return on Assets

-3.16%

N/A

Return on Invested Capital

54.31%

N/A

Free Cash Flow

$983.13K

+14.7%

Operating Cash Flow

$983.13K

+14.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HALBHalberd Corporation

HALBHalberd Corporation$0.00+11.11%

BPTHBio-Path Holdings, Inc.

BPTHBio-Path Holdings, Inc.$0.06+8.50%

EVFMEvofem Biosciences, Inc.

EVFMEvofem Biosciences, Inc.$0.01+7.69%

ISCOInternational Stem Cell Corporation

ISCOInternational Stem Cell Corporation$0.19+22.58%

BMNDFBiomind Labs Inc.

BMNDFBiomind Labs Inc.$0.12+0.00%

CAIHFChia Tai Enterprises International Limited

CAIHFChia Tai Enterprises International Limited$0.28+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About MRZM

What is the current price of Marizyme?

Marizyme is trading at N/A per share.

What is the 52-week range for Marizyme?

Over the past 52 weeks, Marizyme has traded between N/A and $0.00.

How much debt does Marizyme have?

As of the most recent reporting period, Marizyme reported total debt of $26.66M.

How much cash does Marizyme have on hand?

Marizyme reported $63,732 in cash and cash equivalents in its most recent financial results.

What is Marizyme’s dividend yield?

Marizyme does not currently have a dividend yield.

Marizyme

Marizyme Financials at a Glance

MRZM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Marizyme

MRZM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Marizyme Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MRZM

What is the current price of Marizyme?

What is the 52-week range for Marizyme?

How much debt does Marizyme have?

How much cash does Marizyme have on hand?

What is Marizyme’s dividend yield?

Premium Investing Services